Osteoporosis: Treat and Live, or Let Die Twice More Likely

  1. Inicio
  2. »
  3. Sin categoría
  4. »
  5. Osteoporosis: Treat and Live, or Let Die Twice More Likely

J Bone Miner Res. 2015 Sep;30(9):1551-2. doi: 10.1002/jbmr.2601.

The study emphasized that remaining life expectancy is substantial: 13 years for men aged 60 years and 22 years for women aged 60 years. The substantial life expectancy following a fracture exposes patients to increased risk of refracture, which is itself associated with  elevated mortality risk. This underscores the need for evidence of sustained antifracture efficacy, a challenge facing us in the coming years.

Autor: Nguyen TV, Seeman E .
Patrocinadores de la web
Lilly
Laboratorios Rubió
Grupo Italfármaco
UCB-Pharma
Theramex
Stada
Gedeon Richter
Kyowa Kirin
Amgen
Meiji Pharma
Faes Farma